Nilsine Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $316K | Sell |
13,039
-2,166
| -14% | -$52.5K | 0.03% | 312 |
|
|
2025
Q1 | $385K | Buy |
15,205
+3,245
| +27% | +$82.2K | 0.04% | 265 |
|
|
2024
Q4 | $317K | Sell |
11,960
-5,368
| -31% | -$142K | 0.03% | 308 |
|
|
2024
Q3 | $501K | Sell |
17,328
-53
| -0.3% | -$1.53K | 0.07% | 228 |
|
|
2024
Q2 | $486K | Buy |
17,381
+4,197
| +32% | +$117K | 0.07% | 226 |
|
|
2024
Q1 | $366K | Sell |
13,184
-20
| -0.2% | -$555 | 0.05% | 251 |
|
|
2023
Q4 | $380K | Sell |
13,204
-566
| -4% | -$16.3K | 0.06% | 242 |
|
|
2023
Q3 | $457K | Sell |
13,770
-985
| -7% | -$32.7K | 0.07% | 242 |
|
|
2023
Q2 | $541K | Sell |
14,755
-3,029
| -17% | -$111K | 0.08% | 223 |
|
|
2023
Q1 | $726K | Buy |
+17,784
| New | +$726K | 0.11% | 189 |
|